StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report released on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
Bellerophon Therapeutics stock opened at $0.05 on Friday. The business’s 50-day moving average price is $0.06 and its 200 day moving average price is $0.06. The firm has a market cap of $623,730.00, a price-to-earnings ratio of -0.06 and a beta of 0.73. Bellerophon Therapeutics has a 52 week low of $0.03 and a 52 week high of $0.52.
About Bellerophon Therapeutics
Read More
- Five stocks we like better than Bellerophon Therapeutics
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Call Options Volume for These 2 Stocks Spiked Together
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MarketBeat Week in Review – 7/22 – 7/26
- Trading Stocks: RSI and Why it’s Useful
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.